Literature DB >> 4209531

EM49, a new peptide antibiotic. I. Fermentation, isolation, and preliminary characterization.

E Meyers, W E Brown, P A Principe, M L Rathnum, W L Parker.   

Abstract

Mesh：

Substances：

Year:  1973        PMID： 4209531     DOI： 10.7164/antibiotics.26.444

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  7 in total

Review 1.  Structure--activity relationships of polymyxin antibiotics.

Authors:  Tony Velkov; Philip E Thompson; Roger L Nation; Jian Li
Journal:  J Med Chem       Date:  2010-03-11       Impact factor: 7.446

Review 2.  Rediscovering the octapeptins.

Authors:  Tony Velkov; Kade D Roberts; Jian Li
Journal:  Nat Prod Rep       Date:  2017-03-17       Impact factor: 13.423

3.  Investigating the Interaction of Octapeptin A3 with Model Bacterial Membranes.

Authors:  Mei-Ling Han; Hsin-Hui Shen; Karl A Hansford; Elena K Schneider; Sivashangarie Sivanesan; Kade D Roberts; Philip E Thompson; Anton P Le Brun; Yan Zhu; Marc-Antoine Sani; Frances Separovic; Mark A T Blaskovich; Mark A Baker; Samuel M Moskowitz; Matthew A Cooper; Jian Li; Tony Velkov
Journal:  ACS Infect Dis       Date:  2017-07-11       Impact factor: 5.084

4.  Synthesis of octapeptin C4 and biological profiling against NDM-1 and polymyxin-resistant bacteria.

Authors:  Bernd Becker; Mark S Butler; Karl A Hansford; Alejandra Gallardo-Godoy; Alysha G Elliott; Johnny X Huang; David J Edwards; Mark A T Blaskovich; Matthew A Cooper
Journal:  Bioorg Med Chem Lett       Date:  2017-04-12       Impact factor: 2.823

5.  Sputum Active Polymyxin Lipopeptides: Activity against Cystic Fibrosis Pseudomonas aeruginosa Isolates and Their Interactions with Sputum Biomolecules.

Authors:  Elena K Schneider-Futschik; Olivia K A Paulin; Daniel Hoyer; Kade D Roberts; James Ziogas; Mark A Baker; John Karas; Jian Li; Tony Velkov
Journal:  ACS Infect Dis       Date:  2018-04-02       Impact factor: 5.084

6.  Antimicrobial Octapeptin C4 Analogues Active against Cryptococcus Species.

Authors:  Jessica L Chitty; Mark S Butler; Azzah Suboh; David J Edwards; Matthew A Cooper; James A Fraser; Avril A B Robertson
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

Review 7.  Antimicrobial Bacillus: Metabolites and Their Mode of Action.

Authors:  Charlie Tran; Ian E Cock; Xiaojing Chen; Yunjiang Feng
Journal:  Antibiotics (Basel)       Date:  2022-01-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.